PurGenesis Technologies Inc.
3 clinical trials · Sponsor
◉ Watch PurGenesis Technologies Inc.
| Record | Firm | Date |
|---|---|---|
| Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis (NCT03540043) | PurGenesis Technologies Inc. | 2017-10-23 |
Track PurGenesis Technologies Inc. automatically
Every clearance here is in the API, with alerts when new ones post.